Literature DB >> 16954936

Comparison of enhancement, image quality, cost, and adverse reactions using 2 different contrast medium concentrations for routine chest CT on 16-slice MDCT.

Bindu N Setty1, Dushyant V Sahani, Kathy Ouellette-Piazzo, Peter F Hahn, Jo-Anne O Shepard.   

Abstract

OBJECTIVE: To evaluate the degree of enhancement and image quality of chest computed tomographic (CT) examinations on 16-slice multidetector CT using low-concentration [300 milligrams of iodine per milliliter (mg I/mL)] and high-concentration (370 mg I/mL) contrast media; to assess the impact on cost and adverse reactions of the use of high-iodine concentration contrast medium.
MATERIALS AND METHODS: A total of 100 patients scheduled for routine chest CT examinations were administered nonionic contrast medium of 2 strengths: low-iodine concentration contrast medium (300 mg I/mL) [group A: n = 50; male-female ratio, 28:22; mean age, 58.4 years] and high-iodine concentration contrast medium (370 mg I/mL) (group B: n = 50; male-female ratio, 18:32; mean age, 57.6 years) with a constant amount of iodine (400 mg) injected per kilogram of body weight. Contrast media were injected using a dual injector at 2.5 mL/s followed by a 30-mL saline at 2.5 mL/s. The degree of enhancement was quantified by measuring Hounsfield unit values in different arteries and veins and was also rated on a 5-point scale for qualitative assessment. We also evaluated perivenous contrast-related artifacts. The data were compared using Mann-Whitney U test for both qualitative and quantitative enhancement ratings. A value of less than 0.05 was considered statistically significant. The value was adjusted using Bonferroni correction for statistical significance when multiple comparisons were performed. The difference in cost and the incidence of adverse reactions in both groups were calculated.
RESULTS: The mean enhancement values in group B were significantly greater (P < 0.05) than those in group A. The mean Hounsfield units and standard deviation in groups A and B were aorta = 153 +/- 4, 216 +/- 20; pulmonary artery = 147 +/- 10, 208 +/- 20; superior vena cava = 155 +/- 27, 299 +/- 72; and pulmonary vein = 134 +/- 10, 215 +/- 30, respectively. The mean enhancement on a 5-point scale was greater in group B (4.2) than in group A (3.3) (P < 0.01). No significant difference between groups in perivenous artifacts was seen. Up to 5.5% savings in cost resulted from the use of a higher concentration of iodine, with no increase in adverse reactions.
CONCLUSIONS: Use of higher-concentration contrast media provides a higher degree of contrast enhancement and image quality for a routine chest CT on a 16-slice multidetector CT. It also contributes to considerable cost savings with no increased risk of adverse reactions compared with low-concentration contrast media.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954936     DOI: 10.1097/01.rct.0000229999.30897.3b

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  15 in total

Review 1.  Right heart on multidetector CT.

Authors:  D Gopalan
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Thoracic central venous evaluation: comparison of first-pass direct versus delayed-phase indirect multidetector CT venography.

Authors:  Baskaran Sundaram; Jean W Kuriakose; Jadranka Stojanovska; Kuanwong Watcharotone; Robert A Parker; Ella A Kazerooni
Journal:  Clin Imaging       Date:  2015-02-12       Impact factor: 1.605

3.  MDCT angiography of the pulmonary arteries: intravascular contrast enhancement does not depend on iodine concentration when injecting equal amounts of iodine at standardized iodine delivery rates.

Authors:  S Keil; C Plumhans; F F Behrendt; M Das; S Stanzel; G Mühlenbruch; P Seidensticker; C Knackstedt; A H Mahnken; R W Günther; J E Wildberger
Journal:  Eur Radiol       Date:  2008-04-08       Impact factor: 5.315

4.  CT angiography covering both cervical and cerebral arteries using high iodine concentration contrast material with dose reduction on a 16 multidetector-row system.

Authors:  Akira Fujikawa; Kazuhiro Tsuchiya; Masamichi Imai; Toshiaki Nitatori
Journal:  Neuroradiology       Date:  2009-10-16       Impact factor: 2.804

5.  Intra-individual comparison of different contrast media concentrations (300 mg, 370 mg and 400 mg iodine) in MDCT.

Authors:  Florian F Behrendt; Hubertus Pietsch; Gregor Jost; Martin A Sieber; Sebastian Keil; Cedric Plumhans; Peter Seidensticker; Rolf W Günther; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2010-02-24       Impact factor: 5.315

Review 6.  We Built This House; It's Time to Move in: Leveraging Existing DICOM Structure to More Completely Utilize Readily Available Detailed Contrast Administration Information.

Authors:  Jeffrey D Hirsch; Eliot L Siegel; Sridhar Balasubramanian; Kenneth C Wang
Journal:  J Digit Imaging       Date:  2015-08       Impact factor: 4.056

7.  A comparison of the use of contrast media with different iodine concentrations for multidetector CT of the kidney.

Authors:  Seung Chai Jung; Seung Hyup Kim; Jeong Yeon Cho
Journal:  Korean J Radiol       Date:  2011-09-27       Impact factor: 3.500

8.  Quality of CT pulmonary angiography for suspected pulmonary embolus in pregnancy.

Authors:  Jean Marie U-King-Im; Susan J Freeman; Teresa Boylan; Heok K Cheow
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

9.  Which Iodine concentration in chest CT?--a prospective study in 300 patients.

Authors:  Georg Mühlenbruch; Florian F Behrendt; Mohammed A Eddahabi; Christian Knackstedt; Sven Stanzel; Marco Das; Peter Seidensticker; Rolf W Günther; Joachim E Wildberger; Andreas H Mahnken
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

10.  Imaging quality evaluation of low tube voltage coronary CT angiography using low concentration contrast medium.

Authors:  Chengzhong Zhang; Yuejun Yu; Zaixian Zhang; Qingguo Wang; Linfeng Zheng; Yan Feng; Zhiguo Zhou; Guixiang Zhang; Kangan Li
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.